146 related articles for article (PubMed ID: 12220551)
1. Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice.
Taki S
Cytokine Growth Factor Rev; 2002; 13(4-5):379-91. PubMed ID: 12220551
[TBL] [Abstract][Full Text] [Related]
2. Genetic control directed toward spontaneous IFN-alpha/IFN-beta responses and downstream IFN-gamma expression influences the pathogenesis of a murine psoriasis-like skin disease.
Arakura F; Hida S; Ichikawa E; Yajima C; Nakajima S; Saida T; Taki S
J Immunol; 2007 Sep; 179(5):3249-57. PubMed ID: 17709541
[TBL] [Abstract][Full Text] [Related]
3. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling.
Hida S; Ogasawara K; Sato K; Abe M; Takayanagi H; Yokochi T; Sato T; Hirose S; Shirai T; Taki S; Taniguchi T
Immunity; 2000 Nov; 13(5):643-55. PubMed ID: 11114377
[TBL] [Abstract][Full Text] [Related]
4. Type I IFN protects against murine lupus.
Hron JD; Peng SL
J Immunol; 2004 Aug; 173(3):2134-42. PubMed ID: 15265950
[TBL] [Abstract][Full Text] [Related]
5. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
Feng X; Petraglia AL; Chen M; Byskosh PV; Boos MD; Reder AT
J Neuroimmunol; 2002 Aug; 129(1-2):205-15. PubMed ID: 12161037
[TBL] [Abstract][Full Text] [Related]
6. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism.
Stockinger S; Reutterer B; Schaljo B; Schellack C; Brunner S; Materna T; Yamamoto M; Akira S; Taniguchi T; Murray PJ; Müller M; Decker T
J Immunol; 2004 Dec; 173(12):7416-25. PubMed ID: 15585867
[TBL] [Abstract][Full Text] [Related]
7. Dual role of interferon-gamma signalling pathway in sensitivity of pancreatic beta cells to immune destruction.
Gysemans CA; Pavlovic D; Bouillon R; Eizirik DL; Mathieu C
Diabetologia; 2001 May; 44(5):567-74. PubMed ID: 11380074
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells.
Honda K; Mizutani T; Taniguchi T
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2416-21. PubMed ID: 14983024
[TBL] [Abstract][Full Text] [Related]
9. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.
Weber F; Bridgen A; Fazakerley JK; Streitenfeld H; Kessler N; Randall RE; Elliott RM
J Virol; 2002 Aug; 76(16):7949-55. PubMed ID: 12133999
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis.
Ko J; Gendron-Fitzpatrick A; Splitter GA
J Immunol; 2002 Mar; 168(5):2433-40. PubMed ID: 11859135
[TBL] [Abstract][Full Text] [Related]
11. Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus.
Hata N; Sato M; Takaoka A; Asagiri M; Tanaka N; Taniguchi T
Biochem Biophys Res Commun; 2001 Jul; 285(2):518-25. PubMed ID: 11444873
[TBL] [Abstract][Full Text] [Related]
12. Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Salk A; Stobaugh DJ; Deepak P; Ehrenpreis ED
Ann Pharmacother; 2013 Apr; 47(4):537-42. PubMed ID: 23535814
[TBL] [Abstract][Full Text] [Related]
13. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells.
Taki S; Nakajima S; Ichikawa E; Saito T; Hida S
J Immunol; 2005 May; 174(10):6005-12. PubMed ID: 15879093
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.
Matsuyama T; Kimura T; Kitagawa M; Pfeffer K; Kawakami T; Watanabe N; Kündig TM; Amakawa R; Kishihara K; Wakeham A
Cell; 1993 Oct; 75(1):83-97. PubMed ID: 8402903
[TBL] [Abstract][Full Text] [Related]
16. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.
Binder D; Fehr J; Hengartner H; Zinkernagel RM
J Exp Med; 1997 Feb; 185(3):517-30. PubMed ID: 9053452
[TBL] [Abstract][Full Text] [Related]
17. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
Grieder FB; Vogel SN
Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
[TBL] [Abstract][Full Text] [Related]
18. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.
Sato M; Suemori H; Hata N; Asagiri M; Ogasawara K; Nakao K; Nakaya T; Katsuki M; Noguchi S; Tanaka N; Taniguchi T
Immunity; 2000 Oct; 13(4):539-48. PubMed ID: 11070172
[TBL] [Abstract][Full Text] [Related]
19. Role of type I IFNs in pulmonary complications of Pneumocystis murina infection.
Meissner NN; Swain S; Tighe M; Harmsen A; Harmsen A
J Immunol; 2005 May; 174(9):5462-71. PubMed ID: 15843544
[TBL] [Abstract][Full Text] [Related]
20. Role for innate IFNs in determining respiratory syncytial virus immunopathology.
Johnson TR; Mertz SE; Gitiban N; Hammond S; Legallo R; Durbin RK; Durbin JE
J Immunol; 2005 Jun; 174(11):7234-41. PubMed ID: 15905569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
